fibrinogen has been researched along with No-Reflow Phenomenon in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ji, Y; Tang, J; Wang, F; Wang, S; Wang, T; Yang, J; Zhao, Y | 1 |
| Huang, S; Jin, N; Li, T; Li, W; Liu, K; Long, R; Wang, Z; You, Y | 1 |
2 other study(ies) available for fibrinogen and No-Reflow Phenomenon
| Article | Year |
|---|---|
Usefulness of fibrinogen-to-albumin ratio to predict no-reflow and short-term prognosis in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Topics: Aged; Biomarkers; China; Coronary Angiography; Cross-Sectional Studies; Electrocardiography; Female; Fibrinogen; Humans; Male; Middle Aged; Multivariate Analysis; No-Reflow Phenomenon; Percutaneous Coronary Intervention; Prognosis; Proportional Hazards Models; Retrospective Studies; ROC Curve; Serum Albumin, Human; ST Elevation Myocardial Infarction; Time Factors | 2019 |
Sodium tanshinone IIA sulfonate ameliorates experimental coronary no-reflow phenomenon through down-regulation of FGL2.
Topics: Animals; Coronary Circulation; Disease Models, Animal; Down-Regulation; Endothelial Cells; Fibrin; Fibrinogen; Male; No-Reflow Phenomenon; Phenanthrenes; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Receptor, PAR-1; Reperfusion Injury; Signal Transduction | 2015 |